CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 162 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,662,852 | -33.6% | 46,216 | -17.8% | 0.33% | -37.0% |
| Q4 2022 | $2,505,369 | -46.3% | 56,212 | -34.9% | 0.52% | -34.1% |
| Q3 2021 | $4,665,000 | +176.0% | 86,399 | +71.0% | 0.79% | +201.5% |
| Q2 2021 | $1,690,000 | -3.8% | 50,533 | -49.6% | 0.26% | -9.4% |
| Q4 2020 | $1,757,000 | -16.1% | 100,259 | -29.0% | 0.29% | -41.9% |
| Q3 2020 | $2,093,000 | +132.8% | 141,129 | +104.2% | 0.50% | +149.2% |
| Q2 2020 | $899,000 | – | 69,126 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 2,600,000 | $88,218,000 | 12.13% |
| Octagon Capital Advisors LP | 759,898 | $25,783,339 | 3.59% |
| TSP Capital Management Group, LLC | 251,895 | $8,546,800 | 3.08% |
| ACUTA CAPITAL PARTNERS, LLC | 122,343 | $4,151,098 | 2.81% |
| 5AM Venture Management, LLC | 310,270 | $10,527,461 | 2.62% |
| COMMODORE CAPITAL LP | 631,665 | $21,432,393 | 2.41% |
| RTW INVESTMENTS, LP | 3,463,201 | $117,506,410 | 2.24% |
| Eversept Partners, LP | 785,740 | $26,660,158 | 2.23% |
| Redmile Group, LLC | 1,696,004 | $57,545,416 | 2.21% |
| Affinity Asset Advisors, LLC | 87,031 | $2,952,962 | 1.03% |